Minoryx Therapeutics

Minoryx Therapeutics is a clinical-stage biotech company engaged in the development of new therapies for a group of rare diseases of genetic origin. The company focuses its research on orphan CNS diseases affecting the central nervous system.

TypeSubsidiary
Parent CompanyCaixa Capital Risc
HQMataró, ES
Founded2011
Websiteminoryx.com
Cybersecurity ratingAMore
Minoryx Therapeutics was founded in 2011 and is headquartered in Mataró, ES

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Minoryx Therapeutics

Marc Martinell

Marc Martinell

Co-Founder & Chief Executive Officer
Didier le Normand

Didier le Normand

Group CFO & General Manager Belgium
Uwe Meya

Uwe Meya

Chief Medical Officer
María Pascual

María Pascual

Chief Regulatory Officer
Show more

Minoryx Therapeutics Office Locations

Minoryx Therapeutics has offices in Mataró and Charleroi
Mataró, ES (HQ)
Carrer d'Ernest Lluch, 32
Charleroi, BE
Rue Auguste Piccard 48
Show all (2)

Minoryx Therapeutics Financials and Metrics

Summary Metrics

In total, Minoryx Therapeutics had raised $55.6 m. Minoryx Therapeutics is a subsidiary of Caixa Capital Risc

Minoryx Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Minoryx Therapeutics Online and Social Media Presence

Embed Graph

Minoryx Therapeutics News and Updates

Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

Minoryx will receive an upfront and milestone payments of up to $78 million, as well as double digit royalties on annual net sales Sperogenix will receive exclusive rights to develop and commercialize leriglitazone for the treatment of X-linked adrenoleukodystrophy (X-ALD), a rare...

Minoryx Therapeutics Blogs

Minoryx Therapeutics Frequently Asked Questions

  • When was Minoryx Therapeutics founded?

    Minoryx Therapeutics was founded in 2011.

  • Who are Minoryx Therapeutics key executives?

    Minoryx Therapeutics's key executives are Marc Martinell, Didier le Normand and Uwe Meya.

  • How many employees does Minoryx Therapeutics have?

    Minoryx Therapeutics has 27 employees.

  • Who are Minoryx Therapeutics competitors?

    Competitors of Minoryx Therapeutics include Cannabis Sativa, U.S. Stem Cell and Enanta Pharmaceuticals.

  • Where is Minoryx Therapeutics headquarters?

    Minoryx Therapeutics headquarters is located at Carrer d'Ernest Lluch, 32, Mataró.

  • Where are Minoryx Therapeutics offices?

    Minoryx Therapeutics has offices in Mataró and Charleroi.

  • How many offices does Minoryx Therapeutics have?

    Minoryx Therapeutics has 2 offices.